Global Chronic Venous Insufficiency Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Chronic Venous Insufficiency market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chronic Venous Insufficiency is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Chronic Venous Insufficiency is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Chronic Venous Insufficiency is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Chronic Venous Insufficiency is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Chronic Venous Insufficiency include Suzhou Yinluo Medical Devices, Suzhou Tianhong Shengjie Medical Devices, Shanghai Lanmai Medical Technology, Shanghai Ensheng Medical Technology, Hangzhou Weiqiang Medical Technology, Zylox-Tonbridge Medical Technology, Teva, Sun Pharma and Philips, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chronic Venous Insufficiency, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Chronic Venous Insufficiency, also provides the revenue of main regions and countries. Of the upcoming market potential for Chronic Venous Insufficiency, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Venous Insufficiency revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Chronic Venous Insufficiency market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Chronic Venous Insufficiency revenue, projected growth trends, production technology, application and end-user industry.


Chronic Venous Insufficiency Segment by Company

Suzhou Yinluo Medical Devices
Suzhou Tianhong Shengjie Medical Devices
Shanghai Lanmai Medical Technology
Shanghai Ensheng Medical Technology
Hangzhou Weiqiang Medical Technology
Zylox-Tonbridge Medical Technology
Teva
Sun Pharma
Philips
Pfizer
optimed Medizinische Instrumente
Mylan
Medtronic
Cook Ireland
Boston Scientific
BD(Angiomed)
Allergan
AbbVie
Abbott
3M

Chronic Venous Insufficiency Segment by Type

Medical Equipment and Consumables
Drugs

Chronic Venous Insufficiency Segment by Application

Hospital
Clinic
Other

Chronic Venous Insufficiency Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Venous Insufficiency market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Venous Insufficiency and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Venous Insufficiency.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Chronic Venous Insufficiency in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Chronic Venous Insufficiency company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Venous Insufficiency revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Chronic Venous Insufficiency Market by Type
1.2.1 Global Chronic Venous Insufficiency Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Medical Equipment and Consumables
1.2.3 Drugs
1.3 Chronic Venous Insufficiency Market by Application
1.3.1 Global Chronic Venous Insufficiency Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Chronic Venous Insufficiency Market Dynamics
2.1 Chronic Venous Insufficiency Industry Trends
2.2 Chronic Venous Insufficiency Industry Drivers
2.3 Chronic Venous Insufficiency Industry Opportunities and Challenges
2.4 Chronic Venous Insufficiency Industry Restraints
3 Global Growth Perspective
3.1 Global Chronic Venous Insufficiency Market Perspective (2020-2031)
3.2 Global Chronic Venous Insufficiency Growth Trends by Region
3.2.1 Global Chronic Venous Insufficiency Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Chronic Venous Insufficiency Market Size by Region (2020-2025)
3.2.3 Global Chronic Venous Insufficiency Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Chronic Venous Insufficiency Revenue by Players
4.1.1 Global Chronic Venous Insufficiency Revenue by Players (2020-2025)
4.1.2 Global Chronic Venous Insufficiency Revenue Market Share by Players (2020-2025)
4.1.3 Global Chronic Venous Insufficiency Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Chronic Venous Insufficiency Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Chronic Venous Insufficiency Key Players Headquarters & Area Served
4.4 Global Chronic Venous Insufficiency Players, Product Type & Application
4.5 Global Chronic Venous Insufficiency Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Chronic Venous Insufficiency Market CR5 and HHI
4.6.3 2024 Chronic Venous Insufficiency Tier 1, Tier 2, and Tier 3
5 Chronic Venous Insufficiency Market Size by Type
5.1 Global Chronic Venous Insufficiency Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Chronic Venous Insufficiency Revenue by Type (2020-2031)
5.3 Global Chronic Venous Insufficiency Revenue Market Share by Type (2020-2031)
6 Chronic Venous Insufficiency Market Size by Application
6.1 Global Chronic Venous Insufficiency Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Chronic Venous Insufficiency Revenue by Application (2020-2031)
6.3 Global Chronic Venous Insufficiency Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Suzhou Yinluo Medical Devices
7.1.1 Suzhou Yinluo Medical Devices Comapny Information
7.1.2 Suzhou Yinluo Medical Devices Business Overview
7.1.3 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.1.4 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio
7.1.5 Suzhou Yinluo Medical Devices Recent Developments
7.2 Suzhou Tianhong Shengjie Medical Devices
7.2.1 Suzhou Tianhong Shengjie Medical Devices Comapny Information
7.2.2 Suzhou Tianhong Shengjie Medical Devices Business Overview
7.2.3 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.2.4 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio
7.2.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments
7.3 Shanghai Lanmai Medical Technology
7.3.1 Shanghai Lanmai Medical Technology Comapny Information
7.3.2 Shanghai Lanmai Medical Technology Business Overview
7.3.3 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.3.4 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio
7.3.5 Shanghai Lanmai Medical Technology Recent Developments
7.4 Shanghai Ensheng Medical Technology
7.4.1 Shanghai Ensheng Medical Technology Comapny Information
7.4.2 Shanghai Ensheng Medical Technology Business Overview
7.4.3 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.4.4 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio
7.4.5 Shanghai Ensheng Medical Technology Recent Developments
7.5 Hangzhou Weiqiang Medical Technology
7.5.1 Hangzhou Weiqiang Medical Technology Comapny Information
7.5.2 Hangzhou Weiqiang Medical Technology Business Overview
7.5.3 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.5.4 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio
7.5.5 Hangzhou Weiqiang Medical Technology Recent Developments
7.6 Zylox-Tonbridge Medical Technology
7.6.1 Zylox-Tonbridge Medical Technology Comapny Information
7.6.2 Zylox-Tonbridge Medical Technology Business Overview
7.6.3 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.6.4 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio
7.6.5 Zylox-Tonbridge Medical Technology Recent Developments
7.7 Teva
7.7.1 Teva Comapny Information
7.7.2 Teva Business Overview
7.7.3 Teva Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.7.4 Teva Chronic Venous Insufficiency Product Portfolio
7.7.5 Teva Recent Developments
7.8 Sun Pharma
7.8.1 Sun Pharma Comapny Information
7.8.2 Sun Pharma Business Overview
7.8.3 Sun Pharma Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.8.4 Sun Pharma Chronic Venous Insufficiency Product Portfolio
7.8.5 Sun Pharma Recent Developments
7.9 Philips
7.9.1 Philips Comapny Information
7.9.2 Philips Business Overview
7.9.3 Philips Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.9.4 Philips Chronic Venous Insufficiency Product Portfolio
7.9.5 Philips Recent Developments
7.10 Pfizer
7.10.1 Pfizer Comapny Information
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.10.4 Pfizer Chronic Venous Insufficiency Product Portfolio
7.10.5 Pfizer Recent Developments
7.11 optimed Medizinische Instrumente
7.11.1 optimed Medizinische Instrumente Comapny Information
7.11.2 optimed Medizinische Instrumente Business Overview
7.11.3 optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.11.4 optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio
7.11.5 optimed Medizinische Instrumente Recent Developments
7.12 Mylan
7.12.1 Mylan Comapny Information
7.12.2 Mylan Business Overview
7.12.3 Mylan Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.12.4 Mylan Chronic Venous Insufficiency Product Portfolio
7.12.5 Mylan Recent Developments
7.13 Medtronic
7.13.1 Medtronic Comapny Information
7.13.2 Medtronic Business Overview
7.13.3 Medtronic Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.13.4 Medtronic Chronic Venous Insufficiency Product Portfolio
7.13.5 Medtronic Recent Developments
7.14 Cook Ireland
7.14.1 Cook Ireland Comapny Information
7.14.2 Cook Ireland Business Overview
7.14.3 Cook Ireland Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.14.4 Cook Ireland Chronic Venous Insufficiency Product Portfolio
7.14.5 Cook Ireland Recent Developments
7.15 Boston Scientific
7.15.1 Boston Scientific Comapny Information
7.15.2 Boston Scientific Business Overview
7.15.3 Boston Scientific Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.15.4 Boston Scientific Chronic Venous Insufficiency Product Portfolio
7.15.5 Boston Scientific Recent Developments
7.16 BD(Angiomed)
7.16.1 BD(Angiomed) Comapny Information
7.16.2 BD(Angiomed) Business Overview
7.16.3 BD(Angiomed) Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.16.4 BD(Angiomed) Chronic Venous Insufficiency Product Portfolio
7.16.5 BD(Angiomed) Recent Developments
7.17 Allergan
7.17.1 Allergan Comapny Information
7.17.2 Allergan Business Overview
7.17.3 Allergan Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.17.4 Allergan Chronic Venous Insufficiency Product Portfolio
7.17.5 Allergan Recent Developments
7.18 AbbVie
7.18.1 AbbVie Comapny Information
7.18.2 AbbVie Business Overview
7.18.3 AbbVie Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.18.4 AbbVie Chronic Venous Insufficiency Product Portfolio
7.18.5 AbbVie Recent Developments
7.19 Abbott
7.19.1 Abbott Comapny Information
7.19.2 Abbott Business Overview
7.19.3 Abbott Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.19.4 Abbott Chronic Venous Insufficiency Product Portfolio
7.19.5 Abbott Recent Developments
7.20 3M
7.20.1 3M Comapny Information
7.20.2 3M Business Overview
7.20.3 3M Chronic Venous Insufficiency Revenue and Gross Margin (2020-2025)
7.20.4 3M Chronic Venous Insufficiency Product Portfolio
7.20.5 3M Recent Developments
8 North America
8.1 North America Chronic Venous Insufficiency Revenue (2020-2031)
8.2 North America Chronic Venous Insufficiency Revenue by Type (2020-2031)
8.2.1 North America Chronic Venous Insufficiency Revenue by Type (2020-2025)
8.2.2 North America Chronic Venous Insufficiency Revenue by Type (2026-2031)
8.3 North America Chronic Venous Insufficiency Revenue Share by Type (2020-2031)
8.4 North America Chronic Venous Insufficiency Revenue by Application (2020-2031)
8.4.1 North America Chronic Venous Insufficiency Revenue by Application (2020-2025)
8.4.2 North America Chronic Venous Insufficiency Revenue by Application (2026-2031)
8.5 North America Chronic Venous Insufficiency Revenue Share by Application (2020-2031)
8.6 North America Chronic Venous Insufficiency Revenue by Country
8.6.1 North America Chronic Venous Insufficiency Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Chronic Venous Insufficiency Revenue by Country (2020-2025)
8.6.3 North America Chronic Venous Insufficiency Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Chronic Venous Insufficiency Revenue (2020-2031)
9.2 Europe Chronic Venous Insufficiency Revenue by Type (2020-2031)
9.2.1 Europe Chronic Venous Insufficiency Revenue by Type (2020-2025)
9.2.2 Europe Chronic Venous Insufficiency Revenue by Type (2026-2031)
9.3 Europe Chronic Venous Insufficiency Revenue Share by Type (2020-2031)
9.4 Europe Chronic Venous Insufficiency Revenue by Application (2020-2031)
9.4.1 Europe Chronic Venous Insufficiency Revenue by Application (2020-2025)
9.4.2 Europe Chronic Venous Insufficiency Revenue by Application (2026-2031)
9.5 Europe Chronic Venous Insufficiency Revenue Share by Application (2020-2031)
9.6 Europe Chronic Venous Insufficiency Revenue by Country
9.6.1 Europe Chronic Venous Insufficiency Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Chronic Venous Insufficiency Revenue by Country (2020-2025)
9.6.3 Europe Chronic Venous Insufficiency Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Chronic Venous Insufficiency Revenue (2020-2031)
10.2 China Chronic Venous Insufficiency Revenue by Type (2020-2031)
10.2.1 China Chronic Venous Insufficiency Revenue by Type (2020-2025)
10.2.2 China Chronic Venous Insufficiency Revenue by Type (2026-2031)
10.3 China Chronic Venous Insufficiency Revenue Share by Type (2020-2031)
10.4 China Chronic Venous Insufficiency Revenue by Application (2020-2031)
10.4.1 China Chronic Venous Insufficiency Revenue by Application (2020-2025)
10.4.2 China Chronic Venous Insufficiency Revenue by Application (2026-2031)
10.5 China Chronic Venous Insufficiency Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Chronic Venous Insufficiency Revenue (2020-2031)
11.2 Asia Chronic Venous Insufficiency Revenue by Type (2020-2031)
11.2.1 Asia Chronic Venous Insufficiency Revenue by Type (2020-2025)
11.2.2 Asia Chronic Venous Insufficiency Revenue by Type (2026-2031)
11.3 Asia Chronic Venous Insufficiency Revenue Share by Type (2020-2031)
11.4 Asia Chronic Venous Insufficiency Revenue by Application (2020-2031)
11.4.1 Asia Chronic Venous Insufficiency Revenue by Application (2020-2025)
11.4.2 Asia Chronic Venous Insufficiency Revenue by Application (2026-2031)
11.5 Asia Chronic Venous Insufficiency Revenue Share by Application (2020-2031)
11.6 Asia Chronic Venous Insufficiency Revenue by Country
11.6.1 Asia Chronic Venous Insufficiency Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Chronic Venous Insufficiency Revenue by Country (2020-2025)
11.6.3 Asia Chronic Venous Insufficiency Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Chronic Venous Insufficiency Revenue (2020-2031)
12.2 SAMEA Chronic Venous Insufficiency Revenue by Type (2020-2031)
12.2.1 SAMEA Chronic Venous Insufficiency Revenue by Type (2020-2025)
12.2.2 SAMEA Chronic Venous Insufficiency Revenue by Type (2026-2031)
12.3 SAMEA Chronic Venous Insufficiency Revenue Share by Type (2020-2031)
12.4 SAMEA Chronic Venous Insufficiency Revenue by Application (2020-2031)
12.4.1 SAMEA Chronic Venous Insufficiency Revenue by Application (2020-2025)
12.4.2 SAMEA Chronic Venous Insufficiency Revenue by Application (2026-2031)
12.5 SAMEA Chronic Venous Insufficiency Revenue Share by Application (2020-2031)
12.6 SAMEA Chronic Venous Insufficiency Revenue by Country
12.6.1 SAMEA Chronic Venous Insufficiency Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Chronic Venous Insufficiency Revenue by Country (2020-2025)
12.6.3 SAMEA Chronic Venous Insufficiency Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings